A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology (Q35096997)

6 August 2017

A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology (English)

1 reference

6 August 2017

2

Antonio Anzueto

1 reference

6 August 2017

3

Marc Miravitlles

1 reference

6 August 2017

Robert Wilson

1

1 reference

6 August 2017

Pierre Arvis

4

1 reference

6 August 2017

Geneviève Faragó

5

1 reference

6 August 2017

Daniel Haverstock

6

1 reference

6 August 2017

Mila Trajanovic

7

1 reference

6 August 2017

Sanjay Sethi

8

1 reference

6 August 2017

language of work or name

English

0 references

publication date

29 June 2011

1 reference

International Journal of Chronic Obstructive Pulmonary Disease

6 August 2017

1 reference

6 August 2017

6

1 reference

6 August 2017

373-383

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

6 August 2017

start time

1 June 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Direct costs of chronic obstructive pulmonary disease among managed care patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Antibiotics in acute exacerbations of chronic bronchitis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Optimizing antibiotic selection in treating COPD exacerbations

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Strategies for improving outcomes of COPD exacerbations

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Newer fluoroquinolones in the treatment of acute exacerbations of COPD

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

COPD exacerbations: defining their cause and prevention

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Activity limitation and quality of life in COPD.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Chronic obstructive pulmonary disease, risk factors, and outcome trials: comparisons with cardiovascular disease

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Guidelines for the management of adult lower respiratory tract infections

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Clinical significance of the infection-free interval in the management of acute bacterial exacerbations of chronic bronchitis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Acute exacerbations of chronic bronchitis: new developments concerning microbiology and pathophysiology--impact on approaches to risk stratification and therapy

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Antibiotics in the treatment of acute exacerbations of chronic bronchitis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Exacerbations of chronic obstructive pulmonary disease.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

No more equivalence trials for antibiotics in exacerbations of COPD, please

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare

16 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133509

Inflammatory changes, recovery and recurrence at COPD exacerbation

16 November 2018

1 reference

12 December 2020

Acute exacerbation of COPD: factors associated with poor treatment outcome

1 reference

12 December 2020

Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD

1 reference

12 December 2020

The St George's Respiratory Questionnaire

1 reference

12 December 2020

The infection-free interval: its use in evaluating antimicrobial treatment of acute exacerbation of chronic bronchitis

1 reference

12 December 2020

Temporal Clustering of Exacerbations in Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Identifiers

DOI

10.2147/COPD.S21071

1 reference

6 August 2017

1 reference

6 August 2017

1 reference